Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Inari has been the stronger player in PE, with better than 70% share. Importantly, the VTE market remains significantly underpenetrated, with only about 15% to 20% adoption in the U.S. and lower ...

Portage: Stryker, a medical technologies company, has announced a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. for $80 per share in ...

Shares of Inari Medical, Inc. (NASDAQ:NARI) jumped by 22.23 percent or $14.45 to close at $79.45 apiece after medical device maker Stryker on Monday announced that it would acquire the company for ...

NEW YORK: Medical-device maker Stryker has agreed to acquire Inari Medical, which makes devices that treat patients with venous diseases, in an all-cash deal worth US$4.9bil. The deal for Inari ...

New York: Medical-device maker Stryker on Monday agreed to acquire Inari Medical, which makes devices that treat patients with venous diseases, in an all-cash deal worth $4.9 billion. The deal for ...

Stryker will acquire Inari in an all-cash deal for $80 per share, valuing it at roughly $4.9 billion. The deal for the vascular medical device maker was first reported by Reuters Monday afternoon ...

Inari jumped 21% in after hours trading. The medical devices firm will pay $80 a share in cash for Inari (NASDAQ:NARI), according to a statement on Monday. The deal represents a more than 60% ...

NEW YORK (Reuters) -Medical-device maker Stryker is in advanced talks to acquire Inari Medical, which makes devices that treat patients with venous diseases, people familiar with the matter told ...